Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Malin

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
EMBO Molecular Medicine|July 5, 2022
Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS-CoV-2 mRNA vaccinationSebastian J Theobald, Alexander Simonis, Julie M Mudler, et al.
The Cochrane Database of Systematic Reviews|June 17, 2022
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19Caroline Hirsch, Yun Soo Park, Vanessa Piechotta, et al.
Infection|November 3, 2020
Plasma interferon-γ-inducible protein 10 (IP-10) levels correlate with disease severity and paradoxical reactions in extrapulmonary tuberculosisIsabelle Suárez, Samuel Rohr, Melanie Stecher, et al.
HIV Medicine|October 31, 2020
Predictors of serofast state after treatment for early syphilis in HIV-infected patientsG Paul, J Wesselmann, D Adzic, et al.
The Journal of Hospital Infection|July 23, 2021
Outbreak of Pseudomonas aeruginosa infections after CT-guided spinal injectionsG Paul, A Meißner, J Neuneier, et al.
Infection|March 11, 2025
Clinical heterogeneity and treatment outcomes of extrapulmonary tuberculosis in a low-incidence setting: insights from a prospective cohort studyAngela Klingmüller, Marie Feldmann, Samuel Rohr, et al.
Pneumologie (Stuttgart, Germany)|January 15, 2021
[S2k Guideline - Recommendations for Inpatient Therapy of Patients with COVID-19]S Kluge, U Janssens, T Welte, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 4, 2020
Rapid response infrastructure for pandemic preparedness in a tertiary care hospital: lessons learned from the COVID-19 outbreak in Cologne, Germany, February to March 2020Max Augustin, Philipp Schommers, Isabelle Suárez, et al.
Infection|July 6, 2021
Key summary of German national treatment guidance for hospitalized COVID-19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)Jakob J Malin, Christoph D Spinner, Uwe Janssens, et al.
Infection|August 20, 2021
Correction to: Key summary of German national treatment guidance for hospitalized COVID‑19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)Jakob J Malin, Christoph D Spinner, Uwe Janssens, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
EMBO Molecular Medicine|July 5, 2022
Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS-CoV-2 mRNA vaccinationSebastian J Theobald, Alexander Simonis, Julie M Mudler, et al.
The Cochrane Database of Systematic Reviews|June 17, 2022
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19Caroline Hirsch, Yun Soo Park, Vanessa Piechotta, et al.
Infection|November 3, 2020
Plasma interferon-γ-inducible protein 10 (IP-10) levels correlate with disease severity and paradoxical reactions in extrapulmonary tuberculosisIsabelle Suárez, Samuel Rohr, Melanie Stecher, et al.
HIV Medicine|October 31, 2020
Predictors of serofast state after treatment for early syphilis in HIV-infected patientsG Paul, J Wesselmann, D Adzic, et al.
The Journal of Hospital Infection|July 23, 2021
Outbreak of Pseudomonas aeruginosa infections after CT-guided spinal injectionsG Paul, A Meißner, J Neuneier, et al.
Infection|March 11, 2025
Clinical heterogeneity and treatment outcomes of extrapulmonary tuberculosis in a low-incidence setting: insights from a prospective cohort studyAngela Klingmüller, Marie Feldmann, Samuel Rohr, et al.
Pneumologie (Stuttgart, Germany)|January 15, 2021
[S2k Guideline - Recommendations for Inpatient Therapy of Patients with COVID-19]S Kluge, U Janssens, T Welte, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 4, 2020
Rapid response infrastructure for pandemic preparedness in a tertiary care hospital: lessons learned from the COVID-19 outbreak in Cologne, Germany, February to March 2020Max Augustin, Philipp Schommers, Isabelle Suárez, et al.
Infection|July 6, 2021
Key summary of German national treatment guidance for hospitalized COVID-19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)Jakob J Malin, Christoph D Spinner, Uwe Janssens, et al.
Infection|August 20, 2021
Correction to: Key summary of German national treatment guidance for hospitalized COVID‑19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)Jakob J Malin, Christoph D Spinner, Uwe Janssens, et al.
Pageof 11